Vancouver, British Columbia–(Newsfile Corp. – February 5, 2025) – Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) (“Beyond Medical” or the “Company“) is pleased to announce that it has appointed Hongming Luo as a director of the Company. Mr. Luo brings extensive experience in the technology sector, namely focusing on AI, Blockchain and Healthcare Tech, as well as the derivatives markets. Mr. Luo replaces Harveer Sidhu, who has resigned as a director, effective February 4, 2025. The Company would like to thank Mr. Sidhu for his service and wishes him the best in his future endeavors.
On behalf of the Board of Directors
“Daniel Liu” Chief Executive Officer
Email: daniel@republictechs.com
https://beyond-md.ca/
Neither the Canadian Securities Exchange nor its Regulation Services Provider has reviewed or accepts responsibility for the accuracy or adequacy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/239697
Preliminary data from Cohort 4 of the ENSURE study supports a novel enrichment strategy to…
--Data presented at the American College of Cardiology Annual Scientific Session show that the reduction…
Discover the Oral Probiotic That’s Reshaping Dental Health—Backed by 75,000+ Users and Groundbreaking Science ProDentim…
Rybelsus® reduced major adverse cardiovascular events by 14% vs placebo in adults with type 2…
– Lorundrostat 50 mg dose achieved a 15.4 mmHg absolute reduction and 7.9 mmHg placebo-adjusted…
NeuroQuiet Reviews NeuroQuiet VANCOUVER, WA, March 29, 2025 (GLOBE NEWSWIRE) -- NeuroQuiet Reviews In a…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="2px" width="2px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
